Press What’s news at AbelsonTaylor Group
Select category
Top Innovations of 2024: AT Activate
Established in 2012, PM360 introduced the first-ever issue focused entirely on the pharma and healthcare marketing industry’s latest innovations. In 2024, AbelsonTaylor Group’s AT Activate was selected as a leader in Marketing Technology or Services. AT Activate, a full-service media agency, offers advanced end-to-end media strategy capabilities that make high-impact pharmaceutical advertising accessible to brands of all sizes. The solution is transforming the pharmaceutical advertising landscape for clients by leveraging data-driven insights, advanced technologies, and a dynamic approach to consumer, patient and healthcare professional (HCP) engagement. This strategy democratizes DTC high-cost TV buys with digital streaming for smaller brands or rare disease conditions with modest budgets. Read more at https://www.pm360online.com/pm360-2024-innovative-marketing-technology-or-services-at-activate/
Media Contact:
Recent Posts
Social Media Marketing Trends 2025 Report
Thenetworkone just released its annual industry resource on social media trends, including expert insights from AT Group’s Associate Director of Engagement...
In the News Read more Social Media Marketing Trends 2025 ReportAn Indie POV on the Omnicom-Interpublic Merger
AT Group President Jeff Berg recently joined MM+M’s Jack O’Brien to discuss the future of the medical advertising industry in...
Read Press Read more An Indie POV on the Omnicom-Interpublic MergerHow will pharma marketers crack the AI code in 2025?
MM+M January 3, 2025 In the article, “How will pharma marketers crack the AI code in 2025?” AbelsonTaylor Group’s Amy...
In the News Read more How will pharma marketers crack the AI code in 2025?Connect with us
Find out what's top of mind for the people reimagining health and wellness advertising.